
ICON Public Limited Company ICLR
$ 118.48
1.19%
Annual report 2024
added 04-18-2026
ICON Public Limited Company Operating Cycle 2011-2026 | ICLR
Annual Operating Cycle ICON Public Limited Company
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 68.5 | 81.1 | 61.5 | 56.3 | 83.4 | 145 | 148 | 134 | 131 | 141 | 135 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 148 | 56.3 | 108 |
Quarterly Operating Cycle ICON Public Limited Company
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 65.3 | - | 49.3 | 70 | 73.5 | - | 64 | 73.5 | 67.5 | - | 53.9 | 55.6 | 56.3 | - | 54.2 | 56.8 | 56.9 | - | 73 | 74.1 | 80.4 | - | 83.7 | 81 | 88.2 | - | 86.1 | 84.5 | 86.5 | - | 89 | 87.4 | 89.2 | - | 89.4 | 77.4 | 79.4 | - | 73.4 | 69.7 | 72.5 | - | 69.7 | 70.3 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 89.4 | 49.3 | 72.8 |
Operating Cycle of other stocks in the Diagnostics research industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
170 | - | -6.23 % | $ 30.6 M | ||
|
Co-Diagnostics
CODX
|
1.79 K | $ 1.32 | -19.18 % | $ 1.76 M | ||
|
Agilent Technologies
A
|
161 | $ 112.44 | -0.71 % | $ 34.2 B | ||
|
Castle Biosciences
CSTL
|
97.4 | $ 19.2 | 1.69 % | $ 557 M | ||
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M | ||
|
Fulgent Genetics
FLGT
|
77.4 | $ 15.88 | -1.91 % | $ 480 M | ||
|
Aspira Women's Health
AWH
|
1.2 K | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
489 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
134 | - | -13.05 % | $ 7.29 M | ||
|
Illumina
ILMN
|
198 | $ 140.85 | -1.67 % | $ 22.4 B | ||
|
Interpace Biosciences
IDXG
|
96 | $ 1.8 | - | $ 7.96 M | ||
|
CareDx, Inc
CDNA
|
51.5 | $ 19.88 | -2.98 % | $ 1.06 B | ||
|
Chembio Diagnostics
CEMI
|
164 | - | 0.22 % | $ 16.8 M | ||
|
HTG Molecular Diagnostics
HTGM
|
216 | - | -20.0 % | $ 1.06 M | ||
|
Lantheus Holdings
LNTH
|
121 | $ 94.55 | -2.2 % | $ 6.38 B | ||
|
Medpace Holdings
MEDP
|
50.4 | $ 419.78 | 0.15 % | $ 12.1 B | ||
|
Mettler-Toledo International
MTD
|
66.4 | $ 1 051.07 | 0.88 % | $ 21.7 B | ||
|
Global Cord Blood Corporation
CO
|
202 | - | - | $ 399 M | ||
|
Myriad Genetics
MYGN
|
95.1 | $ 3.65 | 0.69 % | $ 338 M | ||
|
Genetic Technologies Limited
GENE
|
11.8 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
185 | - | 0.12 % | $ 80.1 M | ||
|
NeoGenomics
NEO
|
102 | $ 8.32 | -0.54 % | $ 1.07 B | ||
|
DermTech
DMTK
|
114 | - | -11.32 % | $ 2.94 M | ||
|
National Research Corporation
NRC
|
29.4 | $ 18.64 | -1.53 % | $ 417 M | ||
|
Natera
NTRA
|
81.5 | $ 188.14 | -4.45 % | $ 18.5 B | ||
|
Charles River Laboratories International
CRL
|
65 | $ 155.97 | -1.98 % | $ 7.73 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.22 K | - | - | $ 10.7 B | ||
|
Enzo Biochem
ENZ
|
206 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
91.7 | - | - | $ 19.8 B | ||
|
Koninklijke Philips N.V.
PHG
|
89 | $ 25.36 | -0.55 % | $ 24 B | ||
|
Guardant Health
GH
|
128 | $ 93.95 | -4.77 % | $ 11.8 B | ||
|
Personalis
PSNL
|
63.8 | $ 6.56 | -2.24 % | $ 585 M | ||
|
Senseonics Holdings
SENS
|
104 | $ 5.71 | -1.89 % | $ 238 M | ||
|
Heska Corporation
HSKA
|
177 | - | - | $ 1.31 B | ||
|
Soleno Therapeutics
SLNO
|
1.04 K | $ 52.98 | -0.02 % | $ 2.69 B | ||
|
QIAGEN N.V.
QGEN
|
172 | - | - | $ 10.6 B | ||
|
Biomerica
BMRA
|
204 | $ 2.36 | -2.07 % | $ 5.42 M | ||
|
Laboratory Corporation of America Holdings
LH
|
71.8 | $ 252.76 | -0.5 % | $ 21 B | ||
|
Thermo Fisher Scientific
TMO
|
70 | - | - | $ 167 B | ||
|
Trinity Biotech plc
TRIB
|
299 | $ 0.56 | -3.75 % | $ 201 M | ||
|
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K | ||
|
Twist Bioscience Corporation
TWST
|
96.1 | $ 48.6 | -8.22 % | $ 2.91 B | ||
|
Neogen Corporation
NEOG
|
213 | $ 8.32 | -1.25 % | $ 1.8 B | ||
|
Quest Diagnostics Incorporated
DGX
|
54.2 | $ 187.2 | -0.39 % | $ 20.8 B | ||
|
Invitae Corporation
NVTA
|
368 | - | - | $ 21.2 M |